The value and limitations of transgenic mouse models used in drug discovery for Alzheimer's disease: an update
Year: 2012
Type: review
Source: Expert Opinion on Drug Discovery
Author: Kelly R Bales
Institution: Pfizer (United States)
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W1997738202
